Glutathione relates to neuropsychological functioning in mild cognitive impairment

Alzheimer's and Dementia

Volumn 10, Issue 1, 2014, Pages 67-75

  Duffy, Shantel L ^a   Lagopoulos, Jim ^a   Hickie, Ian B ^a   Diamond, Keri ^a   Graeber, Manuel B ^a   Lewis, Simon J G ^a   Naismith, Sharon L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cingulate; Glutathione; Memory; Mild cognitive impairment; Spectroscopy

Indexed keywords

GLUTATHIONE;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; CONTROLLED STUDY; EXECUTIVE FUNCTION; GERIATRIC DEPRESSION SCALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MEMORY; MEMORY CONSOLIDATION; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOLOGIC TEST;

CINGULATE; GLUTATHIONE; MEMORY; MILD COGNITIVE IMPAIRMENT; SPECTROSCOPY;

AGED; AGED, 80 AND OVER; CEREBRAL CORTEX; FEMALE; GLUTATHIONE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PROTONS; PSYCHIATRIC STATUS RATING SCALES; VERBAL LEARNING;

EID: 84891144344     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.01.005     Document Type: Article

References (50)

1. S. Gauthier, B. Reisberg, M. Zaudig, R.C. Petersen, K. Ritchie, and K. Broich et al. Mild cognitive impairment Lancet 367 2006 1262 1270
2. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky, P. Barberger-Gateau, and J. Cummings et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 2007 734 746 (Pubitemid 47058377)
3. K. Kantarci, R.C. Petersen, S.A. Przybelski, S.D. Weigand, M.M. Shiung, and J.L. Whitwell et al. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes Arch Neurol 65 2008 1621 1628
4. R. Rupsingh, M. Borrie, M. Smith, J.L. Wells, and R. Bartha Reduced hippocampal glutamate in Alzheimer disease Neurobiol Aging 32 2011 802 810
5. H.R. Griffith, O.C. Okonkwo, J.A. den Hollander, K. Belue, J. Copeland, and L.E. Harrell et al. Brain metabolic correlates of decision making in amnestic mild cognitive impairment Aging Neuropsychol C 17 2010 492 504
6. B. Halliwell Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment Drugs Aging 18 2001 685 716 (Pubitemid 32948277)
7. R. Dringen Metabolism and functions of glutathione in brain Prog Neurobiol 62 2000 649 671 (Pubitemid 30407139)
8. I. Baldeiras, I. Santana, M.T. Proenca, M.H. Garrucho, R. Pascoal, and A. Rodrigues et al. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease J Alzheimers Dis 15 2008 117 128
9. R. Janaky, V. Varga, A. Hermann, P. Saransaari, and S.S. Oja Mechanisms of L-cysteine neurotoxicity Neurochem Res 25 2000 1397 1405
10. P. Bermejo, S. Martin-Aragon, J. Benedi, C. Susin, E. Felici, and P. Gil et al. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment Free Radic Res 42 2008 162 170 (Pubitemid 351298365)
11. M. Gironi, A. Bianchi, A. Russo, M. Alberoni, L. Ceresa, and A. Angelini et al. Oxidative imbalance in different neurodegenerative diseases with memory impairment Neurodegen Dis 8 2011 129 137
12. M. Padurariu, A. Ciobica, L. Hritcu, B. Stoica, W. Bild, and C. Stefanescu Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease Neurosci Lett 469 2010 6 10
13. M.A. Ansari, and S.W. Scheff Oxidative stress in the progression of Alzheimer disease in the frontal cortex J Neuropathol Exp Neurol 69 2010 155 167
14. R. Sultana, M. Piroddi, F. Galli, and D.A. Butterfield Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment Neurochem Res 33 2008 2540 2546
15. R.B. Mythri, C. Venkateshappa, G. Harish, A. Mahadevan, U.B. Muthane, and T.C. Yasha et al. Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains Neurochem Res 36 2012 1452 1463
16. P.K. Mandal, M. Tripathi, and S. Sugunan Brain oxidative stress: detection and mapping of anti-oxidant marker "glutathione" in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy Biochem Biophys Res Commun 417 2012 43 48
17. S. Minoshima, B. Giordani, S. Berent, K.A. Frey, N.L. Foster, and D.E. Kuhl Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Ann Neurol 42 1997 85 94 (Pubitemid 27304784)
18. N. Villain, M. Fouquet, J.C. Baron, F. Mézenge, B. Landeau, and V. de La Sayette et al. Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease Brain 133 2010 3301 3314
19. J.D. Schmahmann, and D.N. Pandya Fiber pathways of the brain 2006 Oxford University Press New York
20. B.A. Vogt, D.L. Rosene, and D.N. Pandya Thalamic and cortical afferents differentiate anterior from posterior cingulate cortex in the monkey Science 204 1979 205 207 (Pubitemid 9188833)
21. G. Spulber, E. Niskanen, S. MacDonald, M. Kivipelto, D.F. Padilla, and V. Julkunen et al. Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD Curr Alzheimer Res 9 2012 516 524
22. N.C. Fox, W.R. Crum, R.I. Scahill, J.M. Stevens, J.C. Janssen, and M.N. Rossor Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images Lancet 358 2001 201 205 (Pubitemid 32718544)
23. P.J. Nestor, T.D. Fryer, P. Smielewski, and J.R. Hodges Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment Ann Neurol 54 2003 343 351 (Pubitemid 37072036)
24. T.S. Brannan, H.S. Maker, L. Raes, and C. Weiss Regional distribution of glutathione-reductase in the adult-rat brain Brain Res 200 1980 474 477 (Pubitemid 10006968)
25. R.C. Petersen, and J.C. Morris Mild cognitive impairment as a clinical entity and treatment target Arch Neurol 62 2005 1160 1163 (Pubitemid 41043744)
26. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician J Psychiatry Res 12 1975 189 198
27. S.L. Naismith, N.L. Rogers, I.B. Hickie, J. Mackenzie, L.M. Norrie, and S.J.G. Lewis Sleep well, think well: sleep-wake disturbance in mild cognitive impairment J Geriatr Psychiatry Neurol 23 2010 123 130
28. T. Tombaugh Trail Making Test A and B: Normative data stratified by age and education Arch Clin Neuropsychol 19 2004 203 214 (Pubitemid 38316871)
29. M. Lezak Neuropsychological assessment 2nd ed. 1982 Oxford University Press New York
30. G. Senior Analysing RAVLT learning and serial position curves using Mahalanobis distance 1999 University of Southern Queensland Toowoomba
31. D. Delis, and E. Kaplan Delis-Kaplan Executive Function System 2001 Harcourt Brace San Antonio, TX
32. D. Wechsler Manual for the Wechsler Adult Intelligence Scale 3rd ed. 1997 The Psychological Corporation San Antonio, TX
33. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308 (Pubitemid 29120227)
34. B. Reisberg, S.H. Ferris, M.J. Deleon, and T. Crook The global deterioration scale for assessment of primary degenerative dementia Am J Psychiatry 139 1982 1136 1139 (Pubitemid 12051593)
35. J. Talairach, and P. Tournoux Co-planar stereotaxic atlas of the human brain: 3-dimensional proportional system: an approach to cerebral imaging 1987 Thieme New York
36. S.W. Provencher Estimation of metabolite concentrations from localized in-vivo proton NMR-spectra Magn Reson Med 30 1993 672 679 (Pubitemid 23360802)
37. S.J. Wood, G.E. Berger, R.M. Wellard, T.M. Proffitt, M. McConchie, and M. Berk et al. Medial temporal lobe glutathione concentration in first episode psychosis: a H-1-MRS investigation Neurobiol Dis 33 2009 354 357
38. J.M. Allman, A. Hakeem, J.M. Erwin, E. Nimchinsky, and P. Hof The anterior cingulate cortex: the evolution of an interface between emotion and cognition Ann N Y Acad Sci 935 2001 107 117 (Pubitemid 32511395)
39. D. Matsuzawa, T. Obata, Y. Shirayama, H. Nonaka, Y. Kanazawa, and E. Yoshitome et al. Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T H-1-MRS study PLoS One 3 2008 e1944
40. R. Craig-Schapiro, A.M. Fagan, and D.M. Holtzman Biomarkers of Alzheimer's disease Neurobiol Dis 35 2009 128 140
41. M.L. Block NADPH oxidase as a therapeutic target in Alzheimer's disease BMC Neurosci 9 2008 s8
42. L. Li, J. Lu, S. Tay, S. Moochhala, and B. He The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro Brain Res 1159 2007 8 17 (Pubitemid 47058024)
43. J.H.T. Power, and P.C. Blumbergs Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies Acta Neuropathol 117 2009 63 73
44. A. Okello, P. Edison, H.A. Archer, F.E. Turkheimer, J. Kennedy, and R. Bullock et al. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study Neurology 72 2009 56 62
45. R. Janaky, K. Ogita, B.A. Pasqualotto, J.S. Bains, S.S. Oja, and Y. Yoneda et al. Glutathione and signal transduction in the mammalian CNS J Neurochem 73 1999 889 902 (Pubitemid 29395445)
46. J.S. Bains, and C.A. Shaw Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death Brain Res Rev 25 1997 335 358 (Pubitemid 28071452)
47. A. Reynolds, C. Laurie, R.L. Mosley, and E. Howard Oxidative stress and the pathogenesis of neurodegenerative disorders Int Rev Neurobiol 82 2007 297 325
48. C.B. Pocernich, and D.A. Butterfield Elevation of glutathione as a therapeutic strategy in Alzheimer disease Biochim Biophys Acta 1822 2012 625 630
49. S.L. Naismith, N. Glozier, D. Burke, P.E. Carter, E. Scott, and I.B. Hickie Early intervention for cognitive decline: is there a role for multiple medical or behavioural interventions? Early Interv Psychiatry 3 2009 19 27
50. S.A. Frautschy, and G.M. Cole Why pleiotropic interventions are needed for Alzheimer's disease Mol Neurobiol 41 2010 392 409